Leap Therapeutics Inc. buy HC Wainwright
Start price
16.01.25
/
50%
€2.54
Target price
16.01.26
€5.35
Performance (%)
-51.57%
Price
12.12.25
€1.39
Summary
This prediction is currently active. Massive losses of -51.57% have been the result for the BUY prediction by HC_Wainwright. This prediction currently runs until 16.01.26. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Leap Therapeutics Inc. | 44.041% | 44.041% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by HC_Wainwright for this prediction
In the thread Leap Therapeutics Inc diskutieren
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.50 price target on the stock.
Ratings data for LPTX provided by MarketBeat
Stopped prediction by HC_Wainwright for Leap Therapeutics Inc.
Leap Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.32
13.08.24
13.08.24
€5.03
13.08.25
13.08.25
-87.67%
14.08.25
14.08.25
Leap Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.56
14.05.24
14.05.24
€5.09
14.05.25
14.05.25
-85.55%
15.05.25
15.05.25
Leap Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.02
19.03.24
19.03.24
€6.45
19.03.25
19.03.25
-87.43%
20.03.25
20.03.25
Leap Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.48
15.08.23
15.08.23
€6.41
15.08.24
15.08.24
350.00%
16.08.24
16.08.24